SFA News

SFA awards grants to 15 researchers


 

Since its inception, the Sarcoma Foundation of America (SFA) has awarded research grants for the best, most promising research to cure sarcoma. This year SFA awarded $750,000 in research funds to 15 scientists as part of its 2019 SFA Research Grant program. The grants, worth $50,000 each, explore numerous sarcoma subtypes, multiple strategies, and different approaches to find effective treatments for many forms of the disease. Research projects are listed below alphabetically by investigator last name. More details are available on the SFA’s grant pages, available at https://www.curesarcoma.org/grant

Recommended Reading

Health care resource utilization leading to a diagnosis of soft tissue sarcoma
MDedge Hematology and Oncology
More Reports from the Connective Tissue Oncology Society 2018 annual meeting in Rome, November 14-17
MDedge Hematology and Oncology
CAR T cells home in on HER2 in advanced sarcomas
MDedge Hematology and Oncology
From the journals: sarcoma around the world
MDedge Hematology and Oncology
Sarcoma—rare, but not insignificant
MDedge Hematology and Oncology
EHR default order slashes unnecessary imaging during palliative RT
MDedge Hematology and Oncology
FDA approves Turalio for symptomatic tenosynovial giant cell tumor
MDedge Hematology and Oncology
Rozlytrek approved for ROS1-positive metastatic NSCLC, cancers with NTRK gene fusion defects
MDedge Hematology and Oncology
Clinical trials in sarcoma bring hope and promise
MDedge Hematology and Oncology
Significant clinical response induced by vismodegib in advanced sarcoma: Hedgehog pathway inhibition
MDedge Hematology and Oncology